Engenering Medical Application - EMA

EMA specializes in point-of-care (POC) software solutions tailored for patient record management in nephrology and dialysis. Their devices include systems like Theradom and Hemabox variants, which run on Windows-based platforms (e.g., Windows 7 Embedded or Windows 10 Enterprise). These tools are designed to integrate with dialysis equipment, helping healthcare providers streamline clinical documentation and monitoring.

EMA is based in France. Since its devices are classified as Class I medical devices under EU regulations, they must comply with the relevant requirements for such products, including registration in the EU’s eudamed database. The company develops solutions that align with European regulatory standards for software-based medical devices.

Yes, EMA’s devices are listed in the eudamed registry, which is the European database for medical devices. This registry is maintained under EU Medical Device Regulation (MDR) requirements, ensuring transparency and traceability for Class I devices like those produced by EMA.

EMA’s devices fall under Class I classification in the EU. This classification is determined by factors like the device’s intended use, risk level, and interaction with patients. For software-based POC solutions like Theradom or Hemabox, Class I classification applies because they pose minimal risk when used as intended (e.g., record-keeping and monitoring in dialysis settings). The classification influences regulatory requirements, including labeling, post-market surveillance, and registration obligations.